UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.867

Sortiert nach

Al(0.3)Ga(0.7)As / Al(0.05)Ga(0.95)As light-emitting diodes on GaAs-coated Si substrates grown by liquid phase epitaxy

Applied physics letters, 1988-09, Vol.53, p.1201-1203

1988

Link zum Volltext

Verfügbarkeit prüfen

065 Oxidative stress activate the unfolded protein response in keratinocytes resulting in CXCL16 production and CD8+ T cells skin trafficking in vitiligo

Journal of investigative dermatology, 2016-05, Vol.136 (5), p.S12-S12

2016

Link zum Volltext

Verfügbarkeit prüfen

1,1′‐(1,2‐Ethanediyl)bis(2,3‐dihydro‐3‐methyl‐1H‐imidazole‐2‐thione)

Acta crystallographica. Section E, Structure reports online, 2003-03, Vol.59 (3), p.o356-o357

2003

Link zum Volltext

Verfügbarkeit prüfen

1,2,3- versus 1,2-Indeno Ring Fusions Influence Structure Property and Chirality of Corannulene Bowls

Journal of organic chemistry, 2018-04, Vol.83 (7), p.3979-3986

2018

Link zum Volltext

Verfügbarkeit prüfen

1‐(4‐Chlorophenyl)‐3‐(1H‐1,2,4‐triazol‐1‐yl)propan‐1‐one

Acta crystallographica. Section E, Structure reports online, 2004-12, Vol.60 (12), p.o2404-o2405

2004

Link zum Volltext

Verfügbarkeit prüfen

1057P Long-term follow-up of a phase II study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) solid tumors

Annals of oncology, 2023-10, Vol.34, p.S640-S640

2023

Link zum Volltext

Verfügbarkeit prüfen

1080P - A new population model validated pharmacokinetic similarity of HLX01 and rituximab in B-cell lymphoma

Annals of oncology, 2019-10, Vol.30, p.v439-v440

2019

Link zum Volltext

Verfügbarkeit prüfen

1080PA new population model validated pharmacokinetic similarity of HLX01 and rituximab in B-cell lymphoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1213P HRD complete: A novel NGS assay for detecting homologous recombination repair (HRR) gene alterations in prostate cancer

Annals of oncology, 2023-10, Vol.34, p.S713-S713

2023

Link zum Volltext

Verfügbarkeit prüfen

1214P A novel machine learning based method to detect homozygous deletion of homologous recombination repair (HRR) genes in prostate cancer

Annals of oncology, 2023-10, Vol.34, p.S714-S714

2023

Link zum Volltext

Verfügbarkeit prüfen

The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2004-01, Vol.124B (1), p.54-57

2004

Link zum Volltext

Verfügbarkeit prüfen

1243P Influence of home nutritional therapy on body weight in patients with esophageal cancer after surgery: A prospective observational study

Annals of oncology, 2022-09, Vol.33, p.S1117

2022

Link zum Volltext

Verfügbarkeit prüfen

A 12nm FinFET Technology Featuring 2nd Generation FinFET for Low Power and High Performance Applications

2018 IEEE Symposium on VLSI Technology, 2018, p.215-216

2018

Link zum Volltext
IEEE_Xplore

1378P Efficacy and safety of tunlametinib (HL-085) combined with vemurafenib in patients with advanced BRAF V600-mutated solid tumors: A multicenter, phase I study

Annals of oncology, 2023-10, Vol.34, p.S790-S790

2023

Link zum Volltext

Verfügbarkeit prüfen

1380 INCREASED RISK OF COLORECTAL MALIGNANT NEOPLASM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A LARGE CASE–CONTROL STUDY

Journal of hepatology, 2013-04, Vol.58, p.S555-S555

2013

Link zum Volltext

Verfügbarkeit prüfen

1397PLong-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

A 14 nm SoC platform technology featuring 2 super(nd) generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um super(2) SRAM cells, optimized for low power, high performance and high density SoC products

2015 Symposium on VLSI Circuits (VLSI Circuits), 2015-06, p.T12-T13

2015

Link zum Volltext

Verfügbarkeit prüfen

A 14 nm SoC platform technology featuring 2nd generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um2 SRAM cells, optimized for low power, high performance and high density SoC products

2015 Symposium on VLSI Circuits (VLSI Circuits), 2015, p.T12-T13

2015

Link zum Volltext
IEEE_Xplore

A 14 nm SoC platform technology featuring 2nd generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um2 SRAM cells, optimized for low power, high performance and high density SoC products

2015 Symposium on VLSI Technology (VLSI Technology), 2015, p.T12-T13

2015

Link zum Volltext
IEEE_Xplore

1485PD - Safety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30, p.v607-v608

2019

Link zum Volltext

Verfügbarkeit prüfen

1485PDSafety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1531P - Safety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy

Annals of oncology, 2019-10, Vol.30, p.v629-v629

2019

Link zum Volltext

Verfügbarkeit prüfen

1531PSafety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

16 cases of laryngeal keratosis treated with viaminati

Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology, 2000-03, Vol.14 (3), p.108

2000

Link zum Volltext

Verfügbarkeit prüfen

160P - Molecular profiling and prognostic significance of TP53 mutations in diffuse large b cell lymphoma: Identifying a high-risk subgroup

Annals of oncology, 2019-10, Vol.30, p.v50-v50

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.867

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.175)
Mit Volltextzugriff
(4.512)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.260)
Life Sciences & Biomedicine
(1.306)
Physical Sciences
(1.279)
Technology
(1.153)
Physics
(890)
Humans
(881)
Male
(469)
Materials Science
(460)
Female
(459)
Engineering
(458)
Animals
(453)
Materials Science, Multidisciplinary
(358)
Chemistry
(339)
Biological And Medical Sciences
(306)
Exact Sciences And Technology
(296)
Computer Science
(277)
Adult
(256)
Middle Aged
(254)
Science & Technology - Other Topics
(254)
Mice
(243)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Al(0.3)Ga(0.7)As / Al(0.05)Ga(0.95)As light-emitting diodes on GaAs-coated Si substrates grown by liquid phase epitaxy

065 Oxidative stress activate the unfolded protein response in keratinocytes resulting in CXCL16 production and CD8+ T cells skin trafficking in vitiligo

1,1′‐(1,2‐Ethanediyl)bis(2,3‐dihydro‐3‐methyl‐1H‐imidazole‐2‐thione)

1,2,3- versus 1,2-Indeno Ring Fusions Influence Structure Property and Chirality of Corannulene Bowls

1‐(4‐Chlorophenyl)‐3‐(1H‐1,2,4‐triazol‐1‐yl)propan‐1‐one

1057P Long-term follow-up of a phase II study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) solid tumors

1080P - A new population model validated pharmacokinetic similarity of HLX01 and rituximab in B-cell lymphoma

1080PA new population model validated pharmacokinetic similarity of HLX01 and rituximab in B-cell lymphoma

1213P HRD complete: A novel NGS assay for detecting homologous recombination repair (HRR) gene alterations in prostate cancer

1214P A novel machine learning based method to detect homozygous deletion of homologous recombination repair (HRR) genes in prostate cancer

The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans

1243P Influence of home nutritional therapy on body weight in patients with esophageal cancer after surgery: A prospective observational study

A 12nm FinFET Technology Featuring 2nd Generation FinFET for Low Power and High Performance Applications

1378P Efficacy and safety of tunlametinib (HL-085) combined with vemurafenib in patients with advanced BRAF V600-mutated solid tumors: A multicenter, phase I study

1380 INCREASED RISK OF COLORECTAL MALIGNANT NEOPLASM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A LARGE CASE–CONTROL STUDY

1397PLong-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

A 14 nm SoC platform technology featuring 2 super(nd) generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um super(2) SRAM cells, optimized for low power, high performance and high density SoC products

A 14 nm SoC platform technology featuring 2nd generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um2 SRAM cells, optimized for low power, high performance and high density SoC products

A 14 nm SoC platform technology featuring 2nd generation Tri-Gate transistors, 70 nm gate pitch, 52 nm metal pitch, and 0.0499 um2 SRAM cells, optimized for low power, high performance and high density SoC products

1485PD - Safety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer

1485PDSafety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer

1531P - Safety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy

1531PSafety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy

16 cases of laryngeal keratosis treated with viaminati

160P - Molecular profiling and prognostic significance of TP53 mutations in diffuse large b cell lymphoma: Identifying a high-risk subgroup

Suchergebnisse filtern